Dr Sally-Ann Emmas
Sally-Ann is a highly experienced scientist and project leader with over 25 years of experience in Research and Development. Her expertise covers diagnostic and pharmaceutical fields, with experience in pre-clinical and clinical development across different disciplines, with a focus on translational research. Following a PhD in surgical research, Sally-Ann joined GE Healthcare in 1999 as […]
Dr Kirsty Winn
Kirsty Winn is a cell biologist and pharmacologist experienced in early drug discovery and lead generation. Kirsty joined MDC in 2020 as an External Drug Discovery Project Lead; responsible for providing drug discovery advice, scientific due diligence and robust research plans alongside UK medicines discovery innovators. Prior to MDC Kirsty led integrated drug discovery programmes […]
Sarah Brockbank
Sarah Brockbank leads the strategy for Complex Medicines at Medicines Discovery Catapult. In this role she draws on internal expertise and the external environment, through membership of national programmes and a portfolio of client projects, to develop and implement a core strategy for complex medicines that is responsive to the needs of this emerging area. […]
Dr Graeme Wilkinson
Graeme is Head of Virtual R&D at Medicines Discovery Catapult. A pharmacologist by training, and with over 25 years of experience in the industry, Graeme has a track record of successfully leading drug discovery and capability enhancement projects in large pharma and start-up across many disease areas. In addition, Graeme has also significant experience in […]